Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Quantum-Si Inc Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/11/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "BRANFORD, Conn. -- -- Aug. 7, 2023 -- Quantum-Si Incorporated , The Protein Sequencing Company TM , today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights ● Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum TM instruments. ● Strengthened the Board of Directors with the addition of Scott Mendel and Jack Kenny. ● Since May 2023, strengthened the Executive Management team with the additions of Jeff Keyes as Chief Financial Officer and Johan Denecke as Senior Vice President, Operations ● Published five new applications notes since May 2023 demonstrating the use of Quantum-Si’s next-generation protein sequencing across various applications in support of b..."
07/28/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
07/19/2023 8-K Quarterly results
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 SC 13G/A ARK Investment Management LLC reports a 10.5% stake in Quantum-Si Inc.
06/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement, by and between Quantum-Si Incorporated and Claudia Drayton"
05/16/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of the Registrant, as filed with the Secretary of State of the State of Delaware on May 12, 2023"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "GUILFORD, Conn. -- -- May 11, 2023 -- Quantum-Si Incorporated , The Protein Sequencing Company TM , today announced financial results for the first quarter ended March 31, 2023. Recent Highlights ● Revenue was $254,000 on orders of $449,000 in the first quarter of 2023. ● Gross margin was 48.8% in the first quarter of 2023. ● Appointed Jeff Keyes as Chief Financial Officer effective May 15, 2023. ● Strengthened commercial, operations, and development teams with several key executive appointments to help advance commercialization operations. ● Attended Association of Biomolecular Resource Facilities Annual Meeting and exhibited four new application notes. 2023 Financial Outlook ● The Company expects non-GAAP operating expense growth to be approximately fl..."
05/02/2023 8-K Quarterly results
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
03/29/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/29/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/17/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/15/2023 8-K Other Events  Interactive Data
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/06/2023 8-K Quarterly results
03/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Petition of Quantum-Si Incorporated Pursuant to 8 Del. C. § 205"
02/10/2023 SC 13G/A ARK Investment Management LLC reports a 9.9% stake in Quantum-Si Inc.
02/03/2023 SC 13G BlackRock Inc. reports a 5.4% stake in Quantum-Si Inc
01/30/2023 8-K Cost Associated with Exit or Disposal Activities  Interactive Data
01/12/2023 8-K Regulation FD Disclosure  Interactive Data
01/09/2023 8-K Quarterly results
12/20/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/07/2022 8-K Quarterly results
Docs: "GUILFORD, Conn. -- -- Nov. 07, 2022 -- Quantum-Si Incorporated , a life sciences company commercializing the first next-generation, single-molecule protein sequencing platform, today announced financial results for the third quarter ending September 30, 2022."
10/04/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "GUILFORD, Conn. -- -- Oct. 4, 2022 -- Quantum-Si Incorporated , a life sciences company commercializing the first next-generation single-molecule protein sequencing platform, today announced the appointment of Jeff Hawkins as Chief Executive Officer. Mr. Hawkins will succeed Dr. Jonathan Rothberg, Founder and Executive Chairman of Quantum-Si, who has also been serving as Interim Chief Executive Officer, and lead the next phase of growth as the Company prepares to launch the Platinum™ instrument, which will be the industry’s first system to enable next generation, single-molecule protein sequencing. This appointment is effective October 10, 2022. “I’m thrilled to welcome Jeff to Quantum-Si. He is a proven business leader and life sciences inventor with decades of experience driving co..."
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
07/20/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy